PT  - JOURNAL ARTICLE
AU  - Wagner, Caroline E.
AU  - Saad-Roy, Chadi M.
AU  - Morris, Sinead E.
AU  - Baker, Rachel E.
AU  - Mina, Michael J.
AU  - Farrar, Jeremy
AU  - Holmes, Edward C.
AU  - Pybus, Oliver G.
AU  - Graham, Andrea L.
AU  - Emanuel, Ezekiel J.
AU  - Levin, Simon A.
AU  - Metcalf, C. Jessica E.
AU  - Grenfell, Bryan T.
TI  - Vaccine nationalism and the dynamics and control of SARS-CoV-2
AID  - 10.1101/2021.06.02.21258229
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.02.21258229
4099  - http://medrxiv.org/content/early/2021/06/05/2021.06.02.21258229.short
4100  - http://medrxiv.org/content/early/2021/06/05/2021.06.02.21258229.full
AB  - Vaccines provide powerful tools to mitigate the enormous public health and economic costs that the ongoing SARS-CoV-2 pandemic continues to exert globally, yet vaccine distribution remains unequal between countries. To examine the potential epidemiological and evolutionary impacts of ‘vaccine nationalism’, we extend previous models to include simple scenarios of stockpiling. In general, we find that stockpiling vaccines by countries with high availability leads to large increases in infections in countries with low vaccine availability, the magnitude of which depends on the strength and duration of natural and vaccinal immunity. Additionally, a number of subtleties arise when the populations and transmission rates in each country differ depending on evolutionary assumptions and vaccine availability. Furthermore, the movement of infected individuals between countries combined with the possibility of increases in viral transmissibility may greatly magnify local and combined infection numbers, suggesting that countries with high vaccine availability must invest in surveillance strategies to prevent case importation. Dose-sharing is likely a high-return strategy because equitable allocation brings non-linear benefits and also alleviates costs of surveillance (e.g. border testing, genomic surveillance) in settings where doses are sufficient to maintain cases at low numbers. Across a range of immunological scenarios, we find that vaccine sharing is also a powerful tool to decrease the potential for antigenic evolution, especially if infections after the waning of natural immunity contribute most to evolutionary potential. Overall, our results stress the importance of equitable global vaccine distribution.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded in part by Open Philanthropy, the Natural Sciences and Engineering Research Council of Canada through a Postgraduate-Doctoral Scholarship (CMSR), the Cooperative Institute for Modelling the Earth System (CIMES) (REB), the James S. McDonnell Foundation 21st Century Science Initiative Collaborative Award in Understanding Dynamic and Multi-scale Systems (CMSR, SAL), the C3.ai Digital Transformation Institute and Microsoft Corporation (SAL), Gift from Google, LLC (SAL), the National Science Foundation (CNS-2027908, CCF1917819) (SAL), the U.S. CDC (BTG), Flu Lab (BTG).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe manuscript does not include new data